Skip to content
  • Mediacenter
  • Literature Database
  • Investor News
  • Careers
  • Get in Contact
International (English)
Locale
CytoSorbents Europe GmbH
International (English)
Locale
Hotline
  • COVID-19
    • Global decision support
  • The Therapy
    • Therapeutic aspects
    • Ticagrelor and Rivaroxaban
    • Fields of application for the CytoSorb Therapy
    • CytoScore in septic shock
    • Background
    • Product safety
    • Testimonials
  • The Studies
    • Multicenter Studies
    • Monocenter studies
    • The CytoSorb-Registry
    • Case of the week Submission
  • The Adsorber
    • Setup of CytoSorb
    • Usage and Application
    • Technical data
    • Q&A
  • Events
    • Event review
  • Support
    • Mediacenter
    • Reimbursement & Coding of CytoSorb Therapy
    • Newsletter Registration
    • Hotline
  • About us
    • Corporation Management
    • CytoSorbents worldwide
    • Scientific partners
    • Careers
    • Get in Contact

DGTHG 2022: Herausforderung Endokarditis – Welche Patienten profitieren von der CytoSorb-Behandlung?

8. deutschsprachiges CytoSorb Anwendertreffen

8th International CytoSorb Users Meeting

Hemoadsorption with CytoSorb in various cardiac surgery indications

Role of CytoSorb hemoadsorption therapy in endocarditis patients

CytoSorb adsorption for reducing risk of bleeding during cardiac surgery in Ticagrelor/Rivaroxaban

CytoSorb como herramientapara la modulación de estados hiperinflamatorios en Cx cardiaca | 2021

Die CytoSorb-Therapie in der Herzchirurgie – neue Daten und klinische Ergebnisse

CytoSorb therapy in cardiac surgery – New data and clinical results

International Experts Meeting | Cardiac Surgery | Full Version | Webinar 3

International Experts Meeting | Cardiac Surgery | Full Version | Webinar 3

  • February 19, 2021
  • Cardiac Surgery, ECMO
  • SHARE
BACK TO MEDIACENTER

New Videos

International Experts Meeting | Cardiac Surgery | Full Version | Webinar 3
International Experts Meeting | Cardiac Surgery | Full Version | Webinar 3
How we use CytoSorb in daily routine | Lars-Uwe Kühne | Webinar 3
How we use CytoSorb in daily routine | Lars-Uwe Kühne | Webinar 3
Combining ECMO with CytoSorb: when, how and why? | Leonardo Gottin | Webinar 3
Combining ECMO with CytoSorb: when, how and why? | Leonardo Gottin | Webinar 3
The challenge of rhabdomyolysis – we have a new treatment option | Udo Boeken | Webinar 3
The challenge of rhabdomyolysis – we have a new treatment option | Udo Boeken | Webinar 3
  • 1
  • 2
  • 3
  • ...
  • 9
  • Next
CytoSorbents Europe GmbH
Facebook-f Twitter Linkedin Youtube

CytoSorbents Europe GmbH
Müggelseedamm 131
12587 Berlin

support(at)cytosorbents.com

©2022 CYTOSORBENTS EUROPE GMBH | ALL RIGHTS RESERVED

*Cytosorb Therapy is the use of the CytoSorb adsorber in conditions where elevated levels of Cytokines and/or Bilirubin and/or Myoglobin exist. CytoSorb can also be used intraoperatively for the removal of Ticagrelor and/or Rivaroxaban during Cardiopulmonary-Bypass.

  • Privacy Information
  • Data protection
  • Disclaimer
  • Imprint
CytoSorbents Europe GmbH
  • COVID-19
    • Global decision support
  • The Therapy
    • Therapeutic aspects
    • Ticagrelor and Rivaroxaban
    • Fields of application for the CytoSorb Therapy
    • CytoScore in septic shock
    • Background
    • Product safety
    • Testimonials
  • The Studies
    • Multicenter Studies
    • Monocenter studies
    • The CytoSorb-Registry
    • Case of the week Submission
  • The Adsorber
    • Setup of CytoSorb
    • Usage and Application
    • Technical data
    • Q&A
  • Events
    • Event review
  • Support
    • Mediacenter
    • Reimbursement & Coding of CytoSorb Therapy
    • Newsletter Registration
    • Hotline
  • About us
    • Corporation Management
    • CytoSorbents worldwide
    • Scientific partners
    • Careers
    • Get in Contact
APPLY TODAY
JOBS
International (English)
  • Privacy Policy
  • Data protection
  • Disclaimer
  • Imprint